Pediatric drug formulations: challenges and potential solutions

Lack of pediatric drug formulations for both currently marketed and new drugs continues to be a challenge. Marketing of commercial products, along with pediatric indications, would be the ultimate solution to the lack of pediatric drug formulations. However, until that occurs, funding of research on...

Full description

Saved in:
Bibliographic Details
Published in:The Annals of pharmacotherapy 1999-02, Vol.33 (2), p.247-249
Main Author: Nahata, MC
Format: Article
Language:English
Subjects:
Chemistry, Pharmaceutical
Child
Child, Preschool
Dosage Forms
Drug Compounding
Drug Labeling
Humans
Infant
Pediatrics
Research Support as Topic
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c342t-40c79477b00be25819fe2ec23dcf6e1aaf2f92c8a48d703b579b3ab4134ecb633
cites cdi_FETCH-LOGICAL-c342t-40c79477b00be25819fe2ec23dcf6e1aaf2f92c8a48d703b579b3ab4134ecb633
container_end_page 249
container_issue 2
container_start_page 247
container_title The Annals of pharmacotherapy
container_volume 33
creator Nahata, MC
description Lack of pediatric drug formulations for both currently marketed and new drugs continues to be a challenge. Marketing of commercial products, along with pediatric indications, would be the ultimate solution to the lack of pediatric drug formulations. However, until that occurs, funding of research on extemporaneous formulations proposed by scientists should be a high priority. Government, academia, industry, the USPC, and professional associations should collaborate in developing the best policies and an action plan. Infants and children should not be expected to wait for stable extemporaneous formulations of important drugs until an unrealistic goal of having all generic and new drugs available commercially in suitable formulations has been realized.
doi_str_mv 10.1345/aph.18154
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69630926</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1345_aph.18154</sage_id><sourcerecordid>69630926</sourcerecordid><originalsourceid>FETCH-LOGICAL-c342t-40c79477b00be25819fe2ec23dcf6e1aaf2f92c8a48d703b579b3ab4134ecb633</originalsourceid><addsrcrecordid>eNptkMlKxEAQhhtRnHH04AtILgoeMlYv2byIDG4woAc9N51OZRmyjN0Jwbe3nQzowUtVHT7-4v8IOaewpFwEN2pbLmlMA3FA5m4yP2QRHLobQvCBxTAjJ9ZuACChLDkmMwoQC8H4nNy9YVap3lTay8xQeHlnmqFWfdW19tbTpaprbAu0nmozb9v12PaVqj3b1cOOOSVHuaotnu33gnw8Pryvnv3169PL6n7tay5Y7wvQUSKiKAVIkQUxTXJkqBnPdB4iVSpnecJ0rEScRcDTIEpSrlLh6qFOQ84X5GrK3Zruc0Dby6ayGutatdgNVoZJyCFhoQOvJ1CbzlqDudyaqlHmS1KQP7aksyV3thx7sQ8d0gazP-Sk5_erVQXKTTeY1pX8N-lyAsuqKMfKoLSNU-dyqRzHkXPJJBMR_wYIHH7g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69630926</pqid></control><display><type>article</type><title>Pediatric drug formulations: challenges and potential solutions</title><source>SAGE</source><creator>Nahata, MC</creator><creatorcontrib>Nahata, MC</creatorcontrib><description>Lack of pediatric drug formulations for both currently marketed and new drugs continues to be a challenge. Marketing of commercial products, along with pediatric indications, would be the ultimate solution to the lack of pediatric drug formulations. However, until that occurs, funding of research on extemporaneous formulations proposed by scientists should be a high priority. Government, academia, industry, the USPC, and professional associations should collaborate in developing the best policies and an action plan. Infants and children should not be expected to wait for stable extemporaneous formulations of important drugs until an unrealistic goal of having all generic and new drugs available commercially in suitable formulations has been realized.</description><identifier>ISSN: 1060-0280</identifier><identifier>EISSN: 1542-6270</identifier><identifier>DOI: 10.1345/aph.18154</identifier><identifier>PMID: 10084423</identifier><language>eng</language><publisher>United States: Harvey Whitney Books</publisher><subject>Chemistry, Pharmaceutical ; Child ; Child, Preschool ; Dosage Forms ; Drug Compounding ; Drug Labeling ; Humans ; Infant ; Pediatrics ; Research Support as Topic</subject><ispartof>The Annals of pharmacotherapy, 1999-02, Vol.33 (2), p.247-249</ispartof><rights>1999 SAGE Publications</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c342t-40c79477b00be25819fe2ec23dcf6e1aaf2f92c8a48d703b579b3ab4134ecb633</citedby><cites>FETCH-LOGICAL-c342t-40c79477b00be25819fe2ec23dcf6e1aaf2f92c8a48d703b579b3ab4134ecb633</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925,79364</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10084423$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nahata, MC</creatorcontrib><title>Pediatric drug formulations: challenges and potential solutions</title><title>The Annals of pharmacotherapy</title><addtitle>Ann Pharmacother</addtitle><description>Lack of pediatric drug formulations for both currently marketed and new drugs continues to be a challenge. Marketing of commercial products, along with pediatric indications, would be the ultimate solution to the lack of pediatric drug formulations. However, until that occurs, funding of research on extemporaneous formulations proposed by scientists should be a high priority. Government, academia, industry, the USPC, and professional associations should collaborate in developing the best policies and an action plan. Infants and children should not be expected to wait for stable extemporaneous formulations of important drugs until an unrealistic goal of having all generic and new drugs available commercially in suitable formulations has been realized.</description><subject>Chemistry, Pharmaceutical</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Dosage Forms</subject><subject>Drug Compounding</subject><subject>Drug Labeling</subject><subject>Humans</subject><subject>Infant</subject><subject>Pediatrics</subject><subject>Research Support as Topic</subject><issn>1060-0280</issn><issn>1542-6270</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNptkMlKxEAQhhtRnHH04AtILgoeMlYv2byIDG4woAc9N51OZRmyjN0Jwbe3nQzowUtVHT7-4v8IOaewpFwEN2pbLmlMA3FA5m4yP2QRHLobQvCBxTAjJ9ZuACChLDkmMwoQC8H4nNy9YVap3lTay8xQeHlnmqFWfdW19tbTpaprbAu0nmozb9v12PaVqj3b1cOOOSVHuaotnu33gnw8Pryvnv3169PL6n7tay5Y7wvQUSKiKAVIkQUxTXJkqBnPdB4iVSpnecJ0rEScRcDTIEpSrlLh6qFOQ84X5GrK3Zruc0Dby6ayGutatdgNVoZJyCFhoQOvJ1CbzlqDudyaqlHmS1KQP7aksyV3thx7sQ8d0gazP-Sk5_erVQXKTTeY1pX8N-lyAsuqKMfKoLSNU-dyqRzHkXPJJBMR_wYIHH7g</recordid><startdate>19990201</startdate><enddate>19990201</enddate><creator>Nahata, MC</creator><general>Harvey Whitney Books</general><general>SAGE Publications</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19990201</creationdate><title>Pediatric drug formulations: challenges and potential solutions</title><author>Nahata, MC</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c342t-40c79477b00be25819fe2ec23dcf6e1aaf2f92c8a48d703b579b3ab4134ecb633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Chemistry, Pharmaceutical</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Dosage Forms</topic><topic>Drug Compounding</topic><topic>Drug Labeling</topic><topic>Humans</topic><topic>Infant</topic><topic>Pediatrics</topic><topic>Research Support as Topic</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nahata, MC</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Annals of pharmacotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nahata, MC</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pediatric drug formulations: challenges and potential solutions</atitle><jtitle>The Annals of pharmacotherapy</jtitle><addtitle>Ann Pharmacother</addtitle><date>1999-02-01</date><risdate>1999</risdate><volume>33</volume><issue>2</issue><spage>247</spage><epage>249</epage><pages>247-249</pages><issn>1060-0280</issn><eissn>1542-6270</eissn><abstract>Lack of pediatric drug formulations for both currently marketed and new drugs continues to be a challenge. Marketing of commercial products, along with pediatric indications, would be the ultimate solution to the lack of pediatric drug formulations. However, until that occurs, funding of research on extemporaneous formulations proposed by scientists should be a high priority. Government, academia, industry, the USPC, and professional associations should collaborate in developing the best policies and an action plan. Infants and children should not be expected to wait for stable extemporaneous formulations of important drugs until an unrealistic goal of having all generic and new drugs available commercially in suitable formulations has been realized.</abstract><cop>United States</cop><pub>Harvey Whitney Books</pub><pmid>10084423</pmid><doi>10.1345/aph.18154</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1060-0280
ispartof The Annals of pharmacotherapy, 1999-02, Vol.33 (2), p.247-249
issn 1060-0280
1542-6270
language eng
recordid cdi_proquest_miscellaneous_69630926
source SAGE
subjects Chemistry, Pharmaceutical
Child
Child, Preschool
Dosage Forms
Drug Compounding
Drug Labeling
Humans
Infant
Pediatrics
Research Support as Topic
title Pediatric drug formulations: challenges and potential solutions
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T04%3A46%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pediatric%20drug%20formulations:%20challenges%20and%20potential%20solutions&rft.jtitle=The%20Annals%20of%20pharmacotherapy&rft.au=Nahata,%20MC&rft.date=1999-02-01&rft.volume=33&rft.issue=2&rft.spage=247&rft.epage=249&rft.pages=247-249&rft.issn=1060-0280&rft.eissn=1542-6270&rft_id=info:doi/10.1345/aph.18154&rft_dat=%3Cproquest_cross%3E69630926%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c342t-40c79477b00be25819fe2ec23dcf6e1aaf2f92c8a48d703b579b3ab4134ecb633%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=69630926&rft_id=info:pmid/10084423&rft_sage_id=10.1345_aph.18154&rfr_iscdi=true